(Refiles to insert dropped word "Cerezyme" in paragraph 15) * No quick answers to Genzyme's manufacturing woes * Competitors work to upgrade plants, reduce risk By Toni Clarke BOSTON, Oct 20 (Reuters) ...

Genzyme, a company producing therapies for rare diseases, received FDA clearance for its manufacturing plant in Framingham, Mass., for the production of Fabrazyme, an enxyme replacement therapy for ...

NEW YORK, June 16 (Reuters) - Genzyme Corp has halted production of two of its top-selling drugs after detecting a virus at a Boston plant that U.S. regulators had already cited for deficiencies.

The European Medicines Agency (EMA) has approved Genzyme's manufacturing plant in Framingham, Massachusetts, for the production of Fabrazyme (agalsidase beta). “This approval by the EMA represents an ...

The US Food and Drug Administration (FDA) has approved Genzyme's manufacturing plant in Framingham, Massachusetts, for the production of Fabrazyme (agalsidase beta). This follows the previously ...